377 related articles for article (PubMed ID: 29039082)
1. Metal-based proteasomal deubiquitinase inhibitors as potential anticancer agents.
Chen X; Yang Q; Xiao L; Tang D; Dou QP; Liu J
Cancer Metastasis Rev; 2017 Dec; 36(4):655-668. PubMed ID: 29039082
[TBL] [Abstract][Full Text] [Related]
2. A novel nickel complex works as a proteasomal deubiquitinase inhibitor for cancer therapy.
Zhao C; Chen X; Zang D; Lan X; Liao S; Yang C; Zhang P; Wu J; Li X; Liu N; Liao Y; Huang H; Shi X; Jiang L; Liu X; He Z; Dou QP; Wang X; Liu J
Oncogene; 2016 Nov; 35(45):5916-5927. PubMed ID: 27086925
[TBL] [Abstract][Full Text] [Related]
3. Repurposing an antidandruff agent to treating cancer: zinc pyrithione inhibits tumor growth via targeting proteasome-associated deubiquitinases.
Zhao C; Chen X; Yang C; Zang D; Lan X; Liao S; Zhang P; Wu J; Li X; Liu N; Liao Y; Huang H; Shi X; Jiang L; Liu X; Dou QP; Wang X; Liu J
Oncotarget; 2017 Feb; 8(8):13942-13956. PubMed ID: 28086217
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Proteasomal Deubiquitinase by Silver Complex Induces Apoptosis in Non-Small Cell Lung Cancer Cells.
Chen X; Yang Q; Chen J; Zhang P; Huang Q; Zhang X; Yang L; Xu D; Zhao C; Wang X; Liu J
Cell Physiol Biochem; 2018; 49(2):780-797. PubMed ID: 30165348
[TBL] [Abstract][Full Text] [Related]
5. Cadmium pyrithione suppresses tumor growth in vitro and in vivo through inhibition of proteasomal deubiquitinase.
Chen X; Wu J; Yang Q; Zhang X; Zhang P; Liao S; He Z; Wang X; Zhao C; Liu J
Biometals; 2018 Feb; 31(1):29-43. PubMed ID: 29098502
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of 19S proteasome-associated deubiquitinases by metal-containing compounds.
Liu N; Huang H; Dou QP; Liu J
Oncoscience; 2015; 2(5):457-66. PubMed ID: 26097878
[TBL] [Abstract][Full Text] [Related]
7. A novel proteasome inhibitor suppresses tumor growth via targeting both 19S proteasome deubiquitinases and 20S proteolytic peptidases.
Liu N; Liu C; Li X; Liao S; Song W; Yang C; Zhao C; Huang H; Guan L; Zhang P; Liu S; Hua X; Chen X; Zhou P; Lan X; Yi S; Wang S; Wang X; Dou QP; Liu J
Sci Rep; 2014 Jun; 4():5240. PubMed ID: 24912524
[TBL] [Abstract][Full Text] [Related]
8. Discovering proteasomal deubiquitinating enzyme inhibitors for cancer therapy: lessons from rational design, nature and old drug reposition.
Patel K; Ahmed ZS; Huang X; Yang Q; Ekinci E; Neslund-Dudas CM; Mitra B; Elnady FA; Ahn YH; Yang H; Liu J; Dou QP
Future Med Chem; 2018 Sep; 10(17):2087-2108. PubMed ID: 30066579
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of proteasome deubiquitinase activity: a strategy to overcome resistance to conventional proteasome inhibitors?
Selvaraju K; Mazurkiewicz M; Wang X; Gullbo J; Linder S; D'Arcy P
Drug Resist Updat; 2015; 21-22():20-9. PubMed ID: 26183292
[TBL] [Abstract][Full Text] [Related]
10. Targeting the signalling pathways regulated by deubiquitinases for prostate cancer therapeutics.
Islam MT; Zhou X; Chen F; Khan MA; Fu J; Chen H
Cell Biochem Funct; 2019 Jul; 37(5):304-319. PubMed ID: 31062387
[TBL] [Abstract][Full Text] [Related]
11. Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth.
Liu N; Li X; Huang H; Zhao C; Liao S; Yang C; Liu S; Song W; Lu X; Lan X; Chen X; Yi S; Xu L; Jiang L; Zhao C; Dong X; Zhou P; Li S; Wang S; Shi X; Dou PQ; Wang X; Liu J
Oncotarget; 2014 Jul; 5(14):5453-71. PubMed ID: 24977961
[TBL] [Abstract][Full Text] [Related]
12. Identification of 4-arylidene curcumin analogues as novel proteasome inhibitors for potential anticancer agents targeting 19S regulatory particle associated deubiquitinase.
Yue X; Zuo Y; Ke H; Luo J; Lou L; Qin W; Wang Y; Liu Z; Chen D; Sun H; Zheng W; Zhu C; Wang R; Wen G; Du J; Zhou B; Bu X
Biochem Pharmacol; 2017 Aug; 137():29-50. PubMed ID: 28476333
[TBL] [Abstract][Full Text] [Related]
13. A new gold(I) complex-Au(PPh
Li X; Huang Q; Long H; Zhang P; Su H; Liu J
EBioMedicine; 2019 Jan; 39():159-172. PubMed ID: 30527624
[TBL] [Abstract][Full Text] [Related]
14. Platinum pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via DUB inhibition-dependent caspase activation and Bcr-Abl downregulation.
Lan X; Zhao C; Chen X; Zhang P; Zang D; Wu J; Chen J; Long H; Yang L; Huang H; Wang X; Shi X; Liu J
Cell Death Dis; 2017 Jul; 8(7):e2913. PubMed ID: 28682311
[TBL] [Abstract][Full Text] [Related]
15. Deubiquitinases (DUBs) and DUB inhibitors: a patent review.
Farshi P; Deshmukh RR; Nwankwo JO; Arkwright RT; Cvek B; Liu J; Dou QP
Expert Opin Ther Pat; 2015; 25(10):1191-1208. PubMed ID: 26077642
[TBL] [Abstract][Full Text] [Related]
16. Deubiquitinase inhibition as a cancer therapeutic strategy.
D'Arcy P; Wang X; Linder S
Pharmacol Ther; 2015 Mar; 147():32-54. PubMed ID: 25444757
[TBL] [Abstract][Full Text] [Related]
17. Platinum-containing compound platinum pyrithione is stronger and safer than cisplatin in cancer therapy.
Zhao C; Chen X; Zang D; Lan X; Liao S; Yang C; Zhang P; Wu J; Li X; Liu N; Liao Y; Huang H; Shi X; Jiang L; Liu X; He Z; Wang X; Liu J
Biochem Pharmacol; 2016 Sep; 116():22-38. PubMed ID: 27381943
[TBL] [Abstract][Full Text] [Related]
18. Small molecules as tools for functional assessment of deubiquitinating enzyme function.
Magin RS; Liu X; Felix A; Bratt AS; Chan WC; Buhrlage SJ
Cell Chem Biol; 2021 Jul; 28(7):1090-1100. PubMed ID: 34089649
[TBL] [Abstract][Full Text] [Related]
19. The role of deubiquitinating enzymes in cancer drug resistance.
Tanguturi P; Kim KS; Ramakrishna S
Cancer Chemother Pharmacol; 2020 Apr; 85(4):627-639. PubMed ID: 32146496
[TBL] [Abstract][Full Text] [Related]
20. The Emerging Role of Deubiquitinases in Radiosensitivity.
Cao X; Yan Z; Chen Z; Ge Y; Hu X; Peng F; Huang W; Zhang P; Sun R; Chen J; Ding M; Zong D; He X
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1347-1370. PubMed ID: 38092257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
